Milae Bioresources Co., Ltd. (KOSDAQ:218150)

Milae Bioresources Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-	-	-	-	0
Revenue	64,056	62,453	60,016	75,635	66,668	47,497
Revenue Growth (YoY)	0.96%	4.06%	-20.65%	13.45%	40.36%	-5.16%
Cost of Revenue	54,514	54,554	51,911	66,210	58,308	40,821
Gross Profit	9,542	7,900	8,105	9,425	8,361	6,676
Selling, General & Admin	6,268	6,574	6,943	6,757	5,530	4,275
Research & Development	550.26	545.24	534.89	521.61	461.83	504.36
Amortization of Goodwill & Intangibles	350.33	114.02	153.7	183.97	170.86	43.22
Other Operating Expenses	61.48	43.34	40.55	56.06	14.76	15.67
Operating Expenses	8,218	7,716	8,084	7,842	6,506	5,517
Operating Income	1,324	183.74	20.19	1,583	1,855	1,159
Interest Expense	-517.13	-439.5	-399.63	-685.42	-778.2	-235.43
Interest & Investment Income	392.45	731.35	1,008	366.78	116.75	135.58
Currency Exchange Gain (Loss)	31.95	-9.52	-13.87	-4.61	2.25	-14.55
Other Non Operating Income (Expenses)	-26.17	-114.25	-12.44	-63.6	-16.15	41.12
EBT Excluding Unusual Items	1,661	351.81	601.8	1,196	1,180	1,086
Gain (Loss) on Sale of Investments	-	-	1.6	-303.33	-41.2	-54.97
Gain (Loss) on Sale of Assets	35.27	5.88	6.94	12.8	5.73	3.21
Asset Writedown	-875.01	-875.01	-356.45	-	-	-
Other Unusual Items	-	-	139.06	-	-	-
Pretax Income	821.41	-517.31	392.95	905.4	1,144	1,034
Income Tax Expense	-176.52	-97.58	33.74	27.25	65.28	81.11
Earnings From Continuing Operations	997.93	-419.73	359.21	878.15	1,079	953.2
Minority Interest in Earnings	-338.37	-13.77	82.14	84.62	63.79	-1.37
Net Income	659.56	-433.5	441.35	962.77	1,143	951.83
Net Income to Common	659.56	-433.5	441.35	962.77	1,143	951.83
Net Income Growth	91.06%	-	-54.16%	-15.75%	20.05%	-7.57%
Shares Outstanding (Basic)	19	19	19	19	18	18
Shares Outstanding (Diluted)	19	19	19	19	18	18
Shares Change (YoY)	-0.45%	1.34%	2.90%	5.51%	-0.06%	-0.13%
EPS (Basic)	33.88	-22.24	22.94	51.50	64.49	53.68
EPS (Diluted)	33.88	-22.24	22.94	51.00	64.00	53.68
EPS Growth	93.97%	-	-55.02%	-20.31%	19.22%	-7.45%
Free Cash Flow	3,412	-1,069	2,603	706.43	2,452	632.76
Free Cash Flow Per Share	175.27	-54.83	135.29	37.78	138.38	35.69
Gross Margin	14.90%	12.65%	13.50%	12.46%	12.54%	14.06%
Operating Margin	2.07%	0.29%	0.03%	2.09%	2.78%	2.44%
Profit Margin	1.03%	-0.69%	0.73%	1.27%	1.71%	2.00%
Free Cash Flow Margin	5.33%	-1.71%	4.34%	0.93%	3.68%	1.33%
EBITDA	3,404	1,357	1,076	2,612	2,776	1,880
EBITDA Margin	5.31%	2.17%	1.79%	3.45%	4.16%	3.96%
D&A For EBITDA	2,080	1,173	1,056	1,029	920.77	720.23
EBIT	1,324	183.74	20.19	1,583	1,855	1,159
EBIT Margin	2.07%	0.29%	0.03%	2.09%	2.78%	2.44%
Effective Tax Rate	-	-	8.59%	3.01%	5.71%	7.84%
Advertising Expenses	-	331.9	515.17	418.44	106.4	8.68

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.